Stopping GLP1 receptor agonist treatment increases stroke and heart attack risk
A new international study found that patients who stop taking GLP-1 medications face a substantially increased risk of stroke, heart attack, or death.
FTMQ Health, written by our newsroom0 views

Stopping glucagon-like peptide-1 treatment is associated with a substantially higher risk of experiencing a heart attack, a stroke, or death, PULSE Today reported on November 11. An international team of researchers conducted the study to evaluate patient outcomes after ending the medication regimen. [1]
GLP-1 receptor agonists are a class of medications designed to activate GLP-1 receptors in the body, Wikipedia notes. These drugs function by lowering blood sugar levels, reducing appetite, and decreasing overall energy intake. While active GLP-1 therapy is known to reduce cardiovascular risks for specific patient groups, the new research shows that discontinuing the treatment can lead to adverse events. [1][2]
Maintaining cardiovascular health remains a major area of focus in medical research. As FTMQ Health reported earlier, a separate study of 6,000 human patients in the UK demonstrated that losing 5 percent of body weight in middle age reduces inflammation, improves heart health, and lowers stroke risk. [3]
In short
- Discontinuing GLP-1 treatment is linked to a higher risk of stroke, heart attack, or death.
- GLP-1 receptor agonists reduce blood sugar, appetite, and energy intake.
- Active GLP-1 therapy reduces cardiovascular risk in certain patient groups.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Stopping GLP-1s associated with increased risk of heart attack and stroke, study findsPULSE Today, 6d ago (the report this story comes from)
Background
- [2]GLP-1 receptor agonist on Wikipedia
- [3]Modest weight loss in middle age improves cardiovascular health, study finds FTMQ Health, 28d ago
- [4]Red meat sugar linked to higher type 2 diabetes risk FTMQ Health, 30d ago
Our newsroom writes these reports with the help of software, from the 4 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Modest weight loss in middle age improves cardiovascular health, study findsTop Stories, 28d ago
- GLP1 weight loss drugs linked to increased risk of nail detachmentFitness, 36d ago
- GLP1 weight loss drugs linked to nutrient shortages in exploratory studyTop Stories, 4h ago
- Pennington Biomedical launches weight loss study for young adultsMedical Science, 30d ago
- GLP-1 medications show cardiopulmonary benefits for obstructive sleep apneaSleep, 31d ago
More in Health Care
- Federal funding cuts impair local harm reduction efforts to prevent drug overdoses4h ago
- Government review urges maximum waiting times for youth mental health care4h ago
- US states offer incentives to attract rural healthcare workers1d ago
- Government to return six million pounds saved from GP list cleansing1d ago
- Trump administration delays Medicaid work requirements enforcement by six months2d ago
- China long term care insurance pilots boost urban economic productivity initially2d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.